| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |